ISGlobal - Tuberculosis Publications
2024
1. Mariner-Llicer C, Goig GA, Torres-Puente M, Vashakidze S, Villamayor LM, SaavedraCervera B, Mambuque E, Khurtsilava I, Avaliani Z, Rosenthal A, Gabrielian A, Shurgaia M, Shubladze N, García-Basteiro AL, LópezMG, Comas I. Genetic diversitywithin diagnostic sputum samples is mirrored in the culture of Mycobacterium tuberculosis across different settings. Nat Commun 2024;15(1):7114.
2. Centner CM, Munir R, Tagliani E, Rieß F, Brown P, Hayes C, Dolby T, Zemanay W, Cirillo DM, David A, Schumacher SG, Denkinger CM, Ruhwald M, Leukes VN, Nicol MP, Vander Walt I, KistenG, Gumede M, Mace A, Brink A, Stevens W, Scott L, Penn-NicholsonA, Cox H; TB-CAPT Consortium (including Garcia-Basteiro AL). Reflex Xpert MTB/XDR Testing of Residual Rifampicin-Resistant Specimens: A Clinical Laboratory-Based Diagnostic Accuracy and Feasibility Study in South Africa. Open Forum Infect Dis 2024;11(8):ofae437.
3. Mangu C, Cossa M, Ndege R, Khosa C, Leukes V, de la Torre-Pérez L, Machiana A, Kivuma B, Mnzava D, Zachariah C, Manjate P, Tagliani E, Schacht C, Buech J, Singh S, Ehrlich J, Riess F, Sanz S, Kranzer K, Cox H, Sabi I, Nguenha D, Meggi B, Weisser M, Ntinginya N, Schumacher S, Ruhwald M, Penn-NicholsonA, Garcia-Basteiro AL;TB-CAPT Consortium. Expanding Xpert MTB/RIF Ultra® and LF-LAM testing for diagnosis of tuberculosis among HIV-positive adults admitted to hospitals in Tanzania and Mozambique: a randomized controlled trial (the EXULTANT trial). BMC Infect Dis. 2024;24(1):831
4. Churchyard GJ, Houben RMGJ, Fielding K, Fiore-Gartland AL, Esmail H, Grant AD, Rangaka MX, Behr M, Garcia-Basteiro AL, Wong EB, Hatherill M, Mave V, Dagnew AF, Schmidt AC, Hanekom WA, Cobelens F, White RG. Implications of subclinical tuberculosis for vaccine trial design and global effect. Lancet Microbe 2024:S26665247(24)00127-7.
5. Gómez-Valverde JJ, Sánchez-Jacob R, Ribó JL, Schaaf HS, García Delgado L, HernanzLobo A, Capellán-Martín D, Lancharro Á, Augusto O, García-Basteiro AL, Santiago-García B, López-Varela E, Ledesma-Carbayo MJ. Chest X-Ray-Based Telemedicine Platform for Pediatric Tuberculosis Diagnosis in Low-Resource Settings: Development and Validation Study. JMIR Pediatr Parent 2024:7:e51743.
6. Martinez L, Seddon JA, Horsburgh CR, Lange C, Mandalakas AM; TB Contact Studies Consortium (including Garcia-Basteiro AL). Effectiveness of preventive treatment among different age groups and Mycobacterium tuberculosis infection status: a systematic review and individual-participant data meta-analysis of contact tracing studies. Lancet Respir Med. 2024:S2213-2600(24)00083-3.
7. Garcia-Basteiro AL, Ehrlich J, Bonnet M, Calnan M, Graham SM, Hermans S, Jarrett A, Lewa R, Mandalakas A, Martinez L, Migliori GB, Ong CWM, Otero L, Rangaka MX, Raviglione MCB, Seaworth B, Ssengooba W, Theron G, Trajman A, Behr MA. A Global Tuberculosis Dictionary: unified terms and definitions for the field of tuberculosis. Lancet Glob Health 2024:S2214-109X(24)00083-4.
8. Sequera G, Estigarribia-Sanabria G, Aguirre S, Piñanez C, Martinez L, Lopez-Olarte R, Andrews JR, Walter KS, Croda J, Garcia-Basteiro AL. Excess tuberculosis risk during and following incarceration in Paraguay: a retrospective cohort study. Lancet RegHealthAm
2024:31:100668
9. MartínPérezC, Aguilar R, JiménezA, SalmerónG, Canyelles M, Rubio R, Vidal M, Cuamba I, Barrios D, Díaz N, Santano R, Serra P, Santamaria P, Izquierdo L, Trilla A, Vilella A, Barroso S, Tortajada M, García-Basteiro AL, Moncunill G, Dobaño C. Correlates of protection and determinants of SARS-CoV-2 breakthrough infections 1 yearafterthird dose vaccination BMC Med 2024 ;22(1):103.
10. Kay A, Vasiliu A, Carratala L, Mtafya B, Mendez Reyes JE, Maphalala N, Munguambe S, Mulengwa D, Ness T, Saavedra B, Bacha J, Maphalala G, Mejia R, Mtetwa G, Acacio S, Manjate P, Mambuque E, Shiba N, Kota N, Ziyane M, Elias NN, Lange C, Kirchner HN, DiNardo AR, Garcia-Basteiro AL, Mandalakas AM, for the Stool4TB Global Partnership. Performance of a stool-based quantitative polymerase chain reaction assay for the diagnosis of tuberculosis: a multinational prospective study of diagnostic accuracy in adolescents and adults. The Lancet Microbe 2024:S2666-5247(23)00391-9.
11. Carratala-Castro L, Ssengooba, Kay, Acácio S, Ehrlich J DiNardo AR, Shiba N, Nsubuga JK, Munguambe S, Saavedra B, Mandjate P, Mulengwa D, Sibandze B, Ziyane M, Kasule, Mambuque E, Sekadde MP, Wobudeya E, Joloba ML, Heyckendorf J, Lange C, Hermans S, Mandalakas A, García-Basteiro AL, Lopez-Varela E on behalf of Stool4TB Global Partnership. A Stool based qPCR for the diagnosis of TB in children and people living with HIV in Uganda, Eswatini and Mozambique (Stool4TB): a protocol for a multicenter diagnostic evaluation. BMC Infec Dis, 2024. 24(1):233.
12. Sequera G, Aguirre S, Estigarribia G, Walter KS, Horna-Campos O, Liu YE, Andrews JR, Croda J, Garcia-Basteiro AL. Incarceration and TB: the epidemic beyond prison walls. BMJ Glob Health 2024;9(2):e014722
13. Saavedra B, Nguenha D, de la Torre-Pérez L, Mambuque E, Tembe G, Oliveras L, Rudd M, Philimone P, Jose B, Garcia JI, Gomes N, Munguambe S, Chiconela H, Nhanommbe M, Izco S, Acacio S, García-Basteiro AL. Improving tuberculosis case detection through contact risk stratification by Xpert MTB/RIF Ultra and spatial parameters: evaluation of an innovative active case finding strategy in Mozambique (Xpatial-TB). PLOS Glob Public Health. 2024: 4(2):e0002789
14. Cossa M, Nguenha D, Houana A, Ehrlich J, Acácio S, Garcia-Basteiro AL. The urgent need to improve on low implementation rates for TB preventive treatment for people living with HIV. Int J Tuberc Lung Dis 2024: 28(1):1-2.
15. White RG, Fiore-Gartland AJ, Hanekom WA, Vekemans J, Garcia-Basteiro AL, Churchyard G, Rangaka MX, Frick M, Behr MA, Hill PC, Mave V. What is next for BCG revaccination to prevent tuberculosis? Lancet Respir Med 2024 :S2213-2600(24)000092.
16. Leukes VN, Hella J, Sabi I, Cossa M, Khosa C, Erkosar B, Mangu C, Siyame E, Mtafya B, Lwilla A, Viegas S, Madeira C, Machiana A, Ribeiro J, Garcia-Basteiro AL, Riess F, Elísio D, Sasamalo M, Mhalu G, Denkinger CM, Castro MDM, Bashir S, Schumacher SG, Tagliani E, Malhotra A, Dowdy D, Schacht C, Buech J, Nguenha D, Ntinginya N, Ruhwald M, Penn-Nicholson A, Kranzer K; TB-CAPT Consortium. Study protocol: a pragmatic, cluster-randomized controlled trial to evaluate the effect of implementation of the Truenat platform/MTB assays at primary health care clinics in Mozambique and Tanzania (TB-CAPT CORE). BMC Infect Dis. 2024: 19;24(1):107
17. Mariner-Llicer C, Saavedra Cervera B, Mambuque E, Gomes N, Munguambe S, Villamayor L, Cancino-Muñoz I, Torres-Puente M, Nguenha D, Respeito D, Tembe G, López MG, Comas I, García-Basteiro AL. Monitoring of First-line Drug Resistance Mutations
Outside the Scope of Xpert MTB/RIF Ultra is Needed for Successful Control of DR-TB in Southern Mozambique. Clin Infect Dis, 2024;78(4):842-845.
18. Hill PC, Cobelens F, Martinez L, Garcia-Basteiro AL, Behr M, Rangaka MX, Churchyard G, Evans T, Hanekom W, White R. Correspondence Regarding: McShane H. Improving TB vaccine trial efficiency: A tough nut to crack. J Infect Dis 2024;229(2):616.
2023
1. Aguiar Soares K, Ehrlich J, Camará M, Chaloub S, Emeka E, Gando HG, Ismail F, Mvusi L, Jele T, José B, Kgwaadira B, Kisonga R, Letta T, Liega AO, Lungu PS, Maama L, Mahoumbou J, Mbendera K, Ogoro J, Tollo DAD, Sandy C, Saye RG, Sheehama J, Musala S, Tugumisirize D, Carratala L, Cossa M, Garcia-Basteiro AL. Implementation of WHO guidelines on urine lateral flow LAM testing in the high TB/HIV burden African countries. Eur Respir J. 2300556.
2. Narayan A, Salindri AD, Keshavjee S, Muyoyeta M, Velen K, Rueda ZV, Croda J, Charalambous S, García-Basteiro AL, Shenoi SV, Gonçalves CCM, Ferreira da Silva L, Possuelo LG, Aguirre S, Estigarribia G, Sequera G, Grandjean L, Telisinghe L, Herce ME, Dockhorn F, Altice FL, Andrews JR. Prioritizing persons deprived of liberty in global guidelines for tuberculosis preventive treatment. PLoS Med 2023;20(10):e1004288
3. Hill PC, Cobelens F, Martinez L, Behr MA, Churchyard G, Evans T, Fiore-Gartland AJ, Garcia-Basteiro AL, Hanekom W, Rangaka MX, Vekemans J, White RG. An aspiration to radically shorten phase 3 TB vaccine trials. J Infect Dis 2023; jiad356.
4. Mambuque E, Saavedra B, Molina-Moya B, Nguenha D, García-García E, Blanco S, Gomes N, Ehrlich J, Bulo H, Munguambe S, Chiconela H, Acacio S, Domínguez J, García-Basteiro AL. Evaluation of Omnigene-Sputum forPreservation of Sputum Samples forDiagnosis of Mycobacterium tuberculosis. Trop Med Infect Dis 2023; 8(7):367.
5. Martinez L, Garcia-Basteiro AL Targeting ‘Vulnerable’ Populations for Tuberculosis: Does one size fit all? Lancet Inf Dis 2023:S1473-3099(23)00429-2.
6. Nelson KN, Churchyard G, Cobelens F, Hanekom WA, Hill PC, Lopman B, Mave V, Rangaka MX, Vekemans J, White RG, Wong EB, Martinez L, García-Basteiro AL. Measuring indirect transmission-reducing effects in tuberculosis vaccine efficacytrials: why and how? Lancet Microbe 2023;S2666-5247(23)00112-X
7. Izco S, Garcia-Basteiro AL, Denning DW, Boulware DR, Penn-Nicholson A, Letang E. Management of advanced HIV disease in Africa. Lancet HIV 2023; 10(6):e358-e360.
8. Garcia-Basteiro AL, Cobelens F, Ssengooba W, Theron G. Lots of considerations when evaluating the FujiLAM assay Lancet Glob Health 2023; 11(4):e501.
9. Rangaka MX, Frick M, Churchyard G, García-Basteiro AL, Hatherill M, Hanekom W, Hill PC, Hamada Y, Quaife M, Vekemans J, White RG, Cobelens F. Clinical trials of tuberculosis vaccines in the era of increased access to preventive antibiotic treatment Lancet Respir Med 2023 Apr;11(4):380-390.
10. Sanabria GE, Sequera G, Aguirre S, Méndez J, Dos Santos PCP, Gustafson NW, Godoy M, Ortiz A, Cespedes C, Martínez G, García-Basteiro AL, Andrews JR, Croda J, Walter KS. Phylogeographyand transmission of Mycobacterium tuberculosis spanning prisons and surrounding communities in Paraguay, Nat Commun 2023; 14(1):303.
11. Gunasekera KS, Marcy O, Muñoz J, Lopez-Varela E, Sekadde MP, Franke MF, Bonnet M, Ahmed S, AmanullahF, Anwar A, Augusto O, Aurilio RB, Banu S, Batool I, Brands A, Cain KP, Carratalá-Castro L, Caws M, Click ES, Cranmer LM, García-Basteiro AL, Hesseling AC, Huynh J, Kabir S, Lecca L, Mandalakas A, Mavhunga F, Myint AA, Myo K, Nampijja
D, Nicol MP, Orikiriza P, Palmer M, Sant'Anna CC, Siddiqui SA, Smith JP, Song R, Thuong Thuong NT, Ung V, van der Zalm MM, Verkuijl S, Viney K, Walters EG, Warren JL, Zar HJ, Marais BJ, Graham SM, Debray TPA, Cohen T, Seddon JA. Development of treatment decision algorithms for children evaluated for pulmonary tuberculosis: an individual participant data meta-analysis, Lancet Child Adolesc Health 2023;7(5):336-346.
2022
1. Montoya I de Manuel-Rimbau A, Nguenha D, Mambuque E, Ehrlich J, Munguambe S, Saavedra B, Matsena T, Chiconela H, Casellas A, López-Varela E, Acacio S, Garcia-Basteiro AL. Initiation and adherence to isoniazid preventive therapy in children under 5 years of age in Manhiça, Southern Mozambique, J Trop Pediatr 2023;69(1):fmad009.
2. Lazarus JV, Ortiz A, Tyrovolas S, Fernández E, Guy D, White TM, Ma R, Hay SI, Naghavi M, Soriano JB;GBD 2019 SpainCollaborators (includingGarcía-Basteiro AL), AGBD 2019 study of health and Sustainable Development Goal gains and forecasts to 2030 in Spain, Sci Rep 2022;12(1):21154.
3. Miner MD, Hatherill M, Mave V, Gray GE, Nachman S, Read SW, White RG, Hesseling A, Cobelens F, Patel S, Frick M, Bailey T, Seder R, FlynnJ, RengarajanJ, Kaushal D, Hanekom W, Schmidt AC, ScribaTJ, Nemes E, Andersen-NissenE, Landay A, DormanSE, Aldrovandi G, Cranmer LM, Day CL, Garcia-Basteiro AL, Fiore-Gartland A, MoggR, KublinJG, Gupta A, Churchyard G. Developing tuberculosis vaccines for people with HIV: consensus statements from an international expert panel, Lancet HIV 2022; 9(11):e791-e800.
4. GBD 2019 LRI Collaborators, Age-sex differences in the global burden of lower respiratory infections and risk factors, 1990-2019: results from the Global Burden of Disease Study 2019, Lancet Infect Dis 2022; 22(11):1626-1647
5. Martinez L, Cords O, Liu Q, Acuna-Villaorduna C, Bonnet M, Fox GJ, Carvalho AC, PeiChan C, Croda J, Hill PC, Lopez-Varela E, Donkor S, Fielding K, Graham SM, Espinal MA, Kampmann B, Reingold A, Huerga H, Villalba JA, Grandjean L, Sotgiu G, Egere U, Singh S, Zhu L, Lienhardt C, Denholm JT, Seddon JA, Whalen CC, García-Basteiro AL, Triasih R, ChenC, SinghJ, Huang LM, Sharma S, HannounD, Del Corral H, Mandalakas AM, Malone LL, Ling D, Kritski A, Stein CS, Vashishtha R, Boulahbal F, Fang C, Boom WH, Netto EM, Lemos AC, Hesseling AC, Kay A, Jones-López EC, Horsburgh CR, Lange C, Andrews JR. Infant BCG vaccination and risk of pulmonary and extrapulmonary tuberculosis throughout the life course: a systematic review and individual participant data metaanalysis. Lancet Glob Health 2022; 10(9):e1307-e1316.
6. Garcia-Basteiro AL, White RG, Tait D, Schmidt AC, Rangaka MX, Quaife M, Nemes E, Mogg R, Hill PC, Harris RC, Hanekom WA, Frick M, Fiore-Gartland A, Evans T, Dagnew AF, Churchyard G, Cobelens F, Behr MA, Hatherill M. End-point definition and trial design to advance tuberculosis vaccine development. Eur Respir Rev 2022; 31(164):220044.
7. Nguenha D, Cossa M, Acacio S. Garcia-Basteiro AL. Scaling up shorter TB preventive treatment is long overdue Int J Tub L Dis. 2022; 26(8):699-701.
8. Saavedra Cervera B, Gabriella Lopez M, Chiner-Oms A, Garcia AM, Cancino I, TorresPuente M, Villamayor L, Madrazo C, Mambueque E, Sequera VG, Respeito D, Blanco S, Augusto O, Lopez-Varela E, Garcia-Basteiro AL*, Comas I*. Fine-grain population structure and transmission patterns of Mycobacterium tuberculosis in southern Mozambique, a high TB/HIV burden area. Microbial Genomics 2022; 8(7):mgen000844.
* Equal contributors.
9. Meldrum OW, Belchamber KBR, Chichirelo-Konstantynovych KD, Horton KL, Konstantynovych TV, Long MB, McDonnell MJ, Perea L, Garcia-Basteiro AL, Loebinger MR, Duarte R, Keir HR. ERS International Congress 2021: highlights from the Respiratory Infections Assembly. ERJ Open Res 2022; 8(2):00642-2021.
10. Guglielmetti L, Günther G, Leu C, Cirillo D, Duarte R, Garcia-Basteiro AL, Goletti D, Jankovic M, Kuksa L, Maurer FP, Méchaï F, Tiberi S, van LethF, Veziris N, Lange C;Study Group on Mycobacteria of the European Society of Microbiology and Infectious Diseases (ESGMYC), European Society of Mycobacteriology (ESM), European Respiratory Society (ERS) and; Tuberculosis Network European Trials group (TBnet). Rifapentine access in Europe: growing concerns over key tuberculosis treatment component. Eur Respir J. 2022; 59(5):2200388.
11. Delgado LG, Postigo M, Cuadrado D, Gil-Casanova S, Martínez ÁM, Linares M, Merino P, Gimo M, Blanco S, Bassat Q, Santos A, García-Basteiro AL, Ledesma-Carbayo MJ, LuengoOroz MÁ. Remote analysis of sputum smears for mycobacterium tuberculosis quantification using digital crowdsourcing. PLoS One 2022; 17(5):e0268494.
12. Nathavitharana RR, Garcia-Basteiro AL, Ruhwald M, Cobelens F, Theron G. Reimagining the status quo: How close are we to rapid sputum-free tuberculosis diagnostics for all? EbioMedicine 2022; 78:103939.
13. Nguenha D, Acacio S, Murias-Closas A, Ramanlal N, Saavedra B, Karajeanes E, Mudumane B, Mambuque E, Gomes N, Losada I, Oliveras L, Naueia E, Sterling TR, Amorim G, Moon TD, Menéndez C, Vaz P, López-Varela E, Garcia-Basteiro AL. Prevalence and clinical characteristics of pulmonary tuberculosis among pregnant and post-partum women in Mozambique. Int J Tuberc Lung Dis 2022; 26(7):641-649.
14. Migliori GB, Wu SJ, Matteelli A, Zenner D, Goletti D, Ahmedov S, Al-Abri S, Allen DM, Balcells ME, Garcia-Basteiro AL, Cambau E, Chaisson RE, Chee CBE, Dalcolmo MP, Denholm JT, Erkens C, Esposito S, Farnia P, Friedland JS, Graham S, Hamada Y, Harries AD, Kay AW, Kritski A, Manga S, Marais BJ, Menzies D, NgD, Petrone L, RendonA, Silva DR, Schaaf HS, Skrahina A, Sotgiu G, Thwaites G, Tiberi S, Tukvadze N, Zellweger JP, D Ambrosio L, Centis R, Ong CWM. Clinical standards for the diagnosis, treatment and prevention of TB infection Int J Tuberc Lung Dis 2022; 26(3):190-205.
15. Valencia-Aguirre S, Arroyave I, García-Basteiro AL Educational level and tuberculosis mortality in Colombia: growing inequalities and stagnation in reduction. Cad Saude Publica. 2022 Jan; 38(1):e00031721
16. Foo C, Shrestha P, Wang L, Du Q, García-Basteiro AL, Abdullah AS, Legido-Quigley H. Integrating tuberculosis and noncommunicable diseases care in low-and middle-income countries (LMICs): A systematic review. PLoS Med. 2022; 19(1):e1003899
17. GBD 2019 Tuberculosis Collaborators. Global, regional, and national sex differences in the global burden of tuberculosis by HIV status, 1990-2019: results from the Global Burden of Disease Study 2019. Lancet Infect Dis. 2022; 22(2):222-241.
2021
1. Garcia-Basteiro AL, Abimbola S. The challenges of defining global health research. BMJ Glob Health. 2021; 6(12):e008169.
2. Ehrlich J, Garcia-Basteiro AL, Brands A, Verkuijl S, Ndongosieme A, Detjen A, LopezVarela E. Integration of tuberculosis into child health policies in Africa’s high burden countries: A normative analysis. Public Health Action 2021; 11(4):167-170.
3. Churchyard G, Cárdenas V, Chihota V, Mngadi K, Sebe M, Brumskine W, Martinson N, Yimer G, Wang SH, Garcia-Basteiro AL, Nguenha D, Masilela L, Waggie Z, van den Hof S, Charalambous S, Cobelens F, Chaisson RE, Grant AD, FieldingKL; WHIP3TBStudy Team. Annual Tuberculosis Preventive Therapy for Persons With HIV Infection : A Randomized Trial. Ann Intern Med 2021; 174(10):1367-1376.
4. GBD 2019 Under-5 Mortality Collaborators. Global, regional, and national progress towards Sustainable Development Goal 3.2 for neonatal and child health: all-cause and cause-specific mortality findings from the Global Burden of Disease Study 2019. Lancet 2021; 398(10303):870-905.
5. Saavedra B, Mambuque E, Gomes N, Nguenha D, Mabunda R, Faife L, Langa R, Munguambe S, Manjate F, Cossa A, Scott L, García‑Basteiro AL. Diagnostic performance of the Abbott RealTime MTB assayfortuberculosis diagnosis in people living with HIV. Sci Rep 2021; 11(1):19271.
6. Izco S, Murias-Closas A, Jordan AM, Greene G, Catorze N, Chiconela H, Garcia JI, BlancoArevalo A, Febrer A, Casellas A, Saavedra B, Chiller T, Nhampossa T, Garcia-Basteiro A, Letang E. Improved detection and management of advanced HIV disease through a communityadult TB-contact tracing intervention with same-dayprovision ofthe WHOrecommended package of care including ART initiation in a rural district of Mozambique. J Int AIDS Soc. 2021; 24(8):e25775.
7. Saavedra B, Mambuque E, Nguenha D, Gomes N, Munguane S, García JI, Izco S, Acacio S, Murias-Closas A, Cossa M, Losada I, Pernas H, Oliveras L, Theron G, García-Basteiro AL. Performance of Xpert MTB/RIF Ultra for tuberculosis diagnosis in the context of passive and active case finding. Eur Respir J. 2021 (6): 2100257
8. Ranzani OT, Pescarini JM, Martinez L, Garcia-Basteiro AL. Increasing tuberculosis burden in Latin America: an alarming trend forglobal control efforts. BMJ Glob Health. 2021; 6(3):e005639.
9. Rodríguez-Grande C, Hurtado JC, Rodríguez-Maus S, Casas I, Castillo P, Navarro M, Rakislova N, García-Basteiro AL, Carrilho C, Fernandes F, Lovane L, Jordao D, Ismail MR, Lorenzoni C, Cossa A, Mandomando I, Bassat Q, MenéndezC, Ordi J, MuñozP, Pérez-Lago L, García de Viedma D, Martínez MJ. High within-host diversity found from direct genotyping on post-mortem tuberculosis specimens in a high-burden setting. Clin Microbiol Infect. 2021: S1198-743X(21)00286-X
10. Dobaño C, Santano R, Jiménez A, Vidal M, Chi J, Rodrigo Melero N, Popovic M, LópezAladid R, Fernández-Barat L, Tortajada M, Carmona-Torre F, Reina G, Torres A, Mayor A, Carolis C, García-Basteiro AL, Aguilar R, Moncunill G, Izquierdo L. Immunogenicity and crossreactivity of antibodies to the nucleocapsid protein of SARS-CoV-2: utility and limitations in seroprevalence and immunity studies. Transl Res. 2021: S19315244(21)00029-3
11. Menardo F, Rutaihwa LK, Zwyer M, Borrell S, Comas I, Conceição EC, Coscolla M, Cox H, Joloba M, Dou HY, Feldmann J, Fenner L, Fyfe J, Gao Q, García de Viedma D, GarciaBasteiro AL, Gygli SM, Hella J, Hiza H, Jugheli L, Kamwela L, Kato-Maeda M, Liu Q, Ley SD, Loiseau C, Mahasirimongkol S, Malla B, Palittapongarnpim P, Rakotosamimanana N, Rasolofo V, Reinhard M, Reither K, Sasamalo M, Silva Duarte R, Sola C, Suffys P, Batista Lima KV, Yeboah-Manu D, Beisel C, Brites D, Gagneux S. Local adaptation in populations of Mycobacterium tuberculosis endemic to the Indian Ocean Rim. F1000Res. 2021);10:60.
12. Walter KS, Martinez L, Arakaki-SanchezD, Sequera VG, Estigarribia Sanabria G, Cohen T, KoAI, García-BasteiroAL, Rueda XV, LopezOlarteR, EspinalM, CrodaJ, AndrewsJR. The
escalating tuberculosis crisis in Central and South American prisons. Lancet 2021; 397(10284):1591-1596.
13. Dobaño C, Vidal M, Santano R, JiménezA, Chi J, Barrios D, Ruiz-Olalla G, Rodrigo Melero N, Carolis C, Parras D, Serra P, Martínez de Aguirre P, Carmona-Torre F, Reina G, Santamaria P, Mayor A, García-Basteiro AL, Izquierdo L, Aguilar R, Moncunill G. Highly Sensitive and Specific Multiplex Antibody Assays To Quantify Immunoglobulins M, A, and G against SARS-CoV-2 Antigens. J Clin Microbiol. 2021; 59(2):e01731-20.
14. Moncunill G, Mayor A, Santano R, Jiménez A, Vidal M, Tortajada M, Sanz S, Méndez S, Llupià A, Aguilar R, Alonso S, Barrios D, Carolis C, Cisteró P, Chóliz E, Cruz A, Fochs S, Jairoce C, Hecht J, Lamoglia M, Martínez MJ, Moreno J, Mitchell RA, Ortega N, Pey N, Puyol L, Ribes M, Rosell N, Figueroa-Romero A, Sotomayor P, Torres S, Williams S, Barroso S, Vilella A, Trilla A, Varela P, Dobaño C, Garcia-Basteiro AL. SARS-CoV-2 seroprevalence and antibody kinetics among health care workers in a Spanish hospital after three months of follow-up. J Infect Dis. 2021; 223(1):62-71
15. Migliori GB, Tiberi S, García-Basteiro AL, Duarte R. Tuberculosis and its future in the COVID-19 era: The Pulmonology series 2021.Pulmonology 2021; 27(2):94-96
16. Garcia-Basteiro AL, Hurtado JC, Castillo P, Fernandes F, Navarro M, Lovane L, Casas I, Quintó L, Jordao D, Ismail MR, Lorenzoni C, Carrilho C, Sanz A, Rakislova N, Mira A, Alvarez-Martínez MJ, Cossa A, Cobelens F, Mandomando I, Vila J, Bassat Q, Menendez C, Ordi J, Martínez MJ. Performance of the Xpert MTB/RIF Ultra assay for determining cause of death by tuberculosis in tissue samples obtained by minimally invasive autopsies. Chest. 2021; 159(1):103-107
2020
1 Sequera VG, Aguirre S, Estigarribia G, Cellamare M, Croda J, Andrews JR, Martinez L, García-Basteiro AL. Increased incarceration rates drive growing tuberculosis burden in prisons and jeopardize overall tuberculosis control in Paraguay Sci Rep. 2020; 10(1):21247
2 WangJ, & Garcia-Basteiro AL. Should vitamin Dsupplementation be used concomitantly with LTBI treatment? Int J Tub Lung Dis. 2020: 24(9), 875–876.
3 GBD 2019 Risk Factors Collaborators. Global burden of 87 risk factors in 204 countries and territories, 1990-2019: a systematic analysis forthe Global Burden of Disease Study 2019. Lancet 2020; 396(10258), 1223–1249.
4 GBD 2019 Diseases and Injuries Collaborators (2020). Global burden of 369 diseases and injuries in 204countries and territories, 1990-2019: asystematic analysis for the Global Burden of Disease Study 2019. Lancet 2020; 396(10258), 1204–1222.
5 Garcia J, Mambuque E, Nguenha D, Vilanculo F, Sacoor C, Sequera G, Fernández-Quevedo M, La Pierre M, Chiconela H, Faife L, Respeito D, Saavedra B, Nhampossa T, López-Varela E, Garcia-Basteiro AL. Mortality and risk of tuberculosis among people living with HIV in whom tuberculosis was initially ruled out. Sci Rep 2020; 10 (1):15442.
6 Clarke T, Brinkac L, Manoranjan J, García-Basteiro AL, Grewal H, Kiyimba A, Lopez E, Macaden R, Respeito D, Ssengooba W, Tameris M, Sutton G. Typing and classification of non-tuberculous mycobacteria isolates. F1000Research 2020; 9:249.
7 Martinez L, Cords O, Horsburgh CR, Andrews JR,Pediatric TBContact Studies Consortium. The risk of tuberculosis in children after close exposure: a systematic review and individual-participant meta-analysis. Lancet 2020; 395(10228), 973–984
8 Goig GA, Blanco S, Garcia-Basteiro AL, Comas I. Contaminant DNA in bacterial sequencing experiments is a majorsource of false geneticvariability. BMC biology 2020; 18(1), 24
9 Letang E, Ellis J, Naidoo K, Casas EC, Sánchez P, Hassan-Moosa R, Cresswell F, Miró JM, García-Basteiro AL. Tuberculosis-HIV Co-Infection: Progress and Challenges After Two Decades of Global Antiretroviral Treatment Roll-Out. Arch Bronconeumol. 2020; 56 (7): 446-454.
10 Battista Migliori G, Tiberi S, Zumla A, Petersen E, Muhwa Chakaya J, Wejse C, Muñoz Torrico M, Duarte R, Alffenaar JW, Schaaf HS, Marais BJ, Cirillo DM, Alagna R, Rendon A, Pontali E, Piubello A, Figueroa J, Ferlazzo G, García-Basteiro A, Centis R, Visca D, D'Ambrosio L, Sotgiu G; members of the Global Tuberculosis Network. MDR/XDR-TB management of patients and contacts: challenges facing the new decade. The 2020 clinical update by the Global Tuberculosis Network. Int J Infect Dis. 2020; 92S:S15-25.
2019
1. García JI, Kelley HV, Meléndez J, de León RAA, Castillo A, Sidiki S, Yusoof KA, Nunes E, Téllez CL, Mejía-Villatoro CR, Ikeda J, García-Basteiro AL, Wang SH, Torrelles JB. Improved Alere Determine Lipoarabinomannan Antigen Detection Test for the Diagnosis of Human andBovine Tuberculosis byManipulating Urine and Milk Sci Rep. 2019; 9(1):18012.
2. Varo R, Bila R, Saavedra B, Sitoe A, Uamusse A, Ribó-Aristizabal JL, García-Basteiro AL. Paraplegia and spinal deformity in a Mozambican child with Pott's disease and tuberculous scrofula. Lancet 2019; 394(10209):1651.
3. Caminero JA, García-Basteiro AL, Rendon A, Piubello A, Pontali E, Migliori GB. The future of drug-resistant tuberculosis treatment: learning from the past and the 2019 World Health Organization consolidated guidelines. Eur Respir J. 2019; 54(4).
4. GBD 2017 HIV collaborators. Global, regional, and national incidence, prevalence, and mortality of HIV, 1980-2017, and forecasts to 2030, for 195 countries and territories: a systematic analysis for the Global Burden of Diseases, Injuries, and Risk Factors Study 2017. Lancet HIV 2019; 6(12):e831-e859.
5. Ordi J, Castillo P, García-Basteiro AL, Moraleda C, Fernandes F, Quintó L, Hurtado JC, Letang E, Lovane L, Jordao D, Navarro M, Bene R, Nhampossa T, Ismail MR, Lorenzoni C, GuisseveA, Rakislova N, Varo R, Marimon L, SanzA, Cossa A, Mandomando I, Maixenchs M, Munguambe K, Vila J, Macete E, Alonso PL, Bassat Q, Martínez MJ, Carrilho C, Menéndez C, Clinical-pathological discrepancies in the diagnosis of causes of death in adults in Mozambique: A retrospective observational study. PLoS ONE 2019; 14(9): e0220657.
6. Caminero JA, García-Basteiro AL, Rendon A. Multi drug-resistant tuberculosis. Lancet. 2019; 394 (10195):298.
7. García-Basteiro AL, Hurtado JC, Castillo P, Fernandes F, Navarro M, Lovane L, Casas I, Quintó L, Jordao D, Ismail MR, Lorenzoni C, Carrilho C, Sanz A, Rakislova N, Mira A, Alvarez-Martínez MJ, Cossa A, Cobelens F, Mandomando I, Vila J, Bassat Q, Menendez C, Ordi J, MartínezMJ. Unmasking the hidden tuberculosis mortalityburden in a large post mortem study in Maputo Central Hospital, Mozambique. Eur Respir J 2019; 54 (3): 1900312
8. García-Basteiro AL, Jenkins HE, Rangaka The burden of latent multidrug-resistant tuberculosis. Lancet Infectious Diseases 2019; 19(8): 802-803
9. Montenegro-Montero A, García-Basteiro AL Transparency and reproducibility: A step forward, Health Sci Rep 2019; 2(3): e117
10. Nguenha D, Garcia JI, Cowan JF, García-Basteiro AL Spatial epidemiology for tuberculosis surveillance: a relevant add-on to routine surveillance. Int J Tuberc Lung Dis. 2019; 23, (3) 278-279(2)
11. López-Varela E, Respeito D, Blanco S, Gimo M, Sacoor C, Naniche D, García-Basteiro AL High Yield of Home-Based TB Diagnosis Among Newly Diagnosed Patients With HIV. JAIDS 2019; 80 (4): e103-e105.
12. Santos VS, Goletti D, Kontogianni K, Adams ER, Molina-Moya B, Dominguez J, Crudu V, Martins-Filho PRS, Ruhwald M, Lawson L, Bimba JS, Garcia-Basteiro AL, Petrone L, Kabeer BS, Reither K, Cuevas LE. Acute phase proteins and IP-10 as triage tests for the diagnosis of tuberculosis: systematic review and meta-analysis. Clin Microbiol Infect. 2019;25(2):169-177.
2018
1. Nguenha D, Manhiça I, Garcia-Basteiro AL, Cowan J, Tuberculosis in Mozambique: Where Do We Stand? Current Tropical Medicine Reports 2018; 5 (4) 264–272.
2. GBD Tuberculosis Collaborators. Global, regional, and national burden of tuberculosis, 1990-2016: results from the Global Burden of Diseases, Injuries, and Risk Factors 2016 Study, Lancet Infect Dis. 2018; 18 (12):1329-1349.
3. GBD 2017 SDG Collaborators. Measuring progress from 1990 to 2017 and projecting attainment to 2030 of the health-related Sustainable Development Goals for 195 countries and territories: a systematic analysis for the Global Burden of Disease Study 2017. Lancet 2018; 392 (10159):2091-2138.
4. GBD 2017 Risk Factor Collaborators. Global, regional, and national comparative risk assessment of 84 behavioural, environmental and occupational, and metabolic risks or clusters of risks for 195 countries and territories, 1990-2017: a systematic analysis for the Global Burden of Disease Study 2017. Lancet 2018; 392 (10159) 1923-1994.
5. GBD 2017 Disease and Injury Incidence and Prevalence Collaborators. Global, regional, and national incidence, prevalence, and years lived with disability for 354 diseases and injuries for195 countries and territories, 1990-2017: asystematic analysis forthe Global Burden of Disease Study 2017. Lancet 2018; 392 (10159):1789-1858.
6. GBD 2017 Causes of Death Collaborators. Global, regional, and national age-sex-specific mortality for 282 causes of death in 195 countries and territories, 1980-2017: a systematic analysis for the Global Burden of Disease Study 2017 Lancet 2018; 392(10159):1736-1788.
7. GBD 2017 Mortality Collaborators. Global, regional, and national age-sex-specific mortality and life expectancy, 1950-2017: a systematic analysis for the Global Burden of Disease Study 2017. Lancet 2018; 392 (10159):1684-1735.
8. GBD 2017 DALYs and HALE Collaborators. Global, regional, and national disabilityadjusted life-years (DALYs) for 359 diseases and injuries and healthy life expectancy (HALE) for 195 countries and territories, 1990-2017: a systematic analysis for the Global Burden of Disease Study 2017. Lancet 2018; 392 (10159):1859-1922.
9. Chol C, Negin J, Garcia-Basteiro A, Gebrehiwot TG, Debru B, Chimpolo M, Agho K, CummingRG, Abimbola S. Health system reforms in five sub-Saharan African countries that experienced major armed conflicts (wars) during 1990-2015: a literature review. Glob Health Action 2018; 11 (1):1517931, p1654-9880.
10. GBD 2016 Lower Respiratory Infections Collaborators. Estimates of the global, regional, and national morbidity, mortality, and aetiologies of lower respiratory infections in 195 countries, 1990-2016: asystematic analysis forthe Global Burden of Disease Study2016. Lancet Infect Dis 2018; 18 (11):1191-1210.
11. Soriano JB, Rojas-Rueda D, Alonso J, Antó JM, Cardona PJ, Fernández E, García-Basteiro AL, Benavides FG, Glenn SD, Krish V, Lazarus JV, Martínez-Raga J, Masana MF, Nieuwenhuijsen MJ, Ortíz A, Sánchez-Niño MD, Serrano-Blanco A, Tortajada-Girbés M, Tyrovolas S, Haro JM, Naghavi M, Murray CJL, Colaboradores de GBD en España, The burden of disease in Spain: Results from the Global Burden of Disease 2016. Medicine Clinical 2018; 151 (5): 171-190
12. Mambuque ET, Abascal E, Venter R, Bulo H, Bouza E, Theron G, García-Basteiro AL, García-de-Viedma D, Direct genotyping of Mycobacterium tuberculosis from Xpert® MTB/RIF remnants. Tuberculosis 2018; 111: 202-206.
13. García-Basteiro AL, Brew J, Williams B, Borgdorff M, Cobelens F, What is the true tuberculosis mortality burden? Differences in estimates by the World Health Organization and the Global Burden of Disease study. International Journal of Epidemiology 2018; 47 (5): 1549-1560
14. Beynon F, Theron G, Respeito D, Mambuque E, Saavedra B, Bulo H, Sanz S, Dheda K, García-Basteiro AL Correlation of Xpert MTB/RIF with measures to assess Mycobacterium tuberculosis bacillary burden in high HIV burden areas of Southern Africa. Sci Rep 2018; 8(1): 5201
15. Migliori GB, García-Basteiro AL. Predicting the effect of improved socioeconomic health determinants on the tuberculosis epidemic. Lancet Glob Health 2018; 6 (5): e475-e476.
16. Marbán-Castro E, Sacoor C, Nhacolo A, Augusto O, Jamisse E, López-Varela E, Casellas A, Aponte JJ, Bassat Q, Sigaúque B, Macete E, García-Basteiro AL, BCG vaccination in southern rural Mozambique: an overview of coverage and its determinants based on data from the demographic and health surveillance system in the district of Manhiça. BMC Pediatrics 2018; 18 (1): 56.
17. García-Basteiro AL, Schaaf HS, Diel R, Migliori GB, Adolescents and young adults: a neglected population group for tuberculosis surveillance. Eur Respir J 2018; 51 (2)
18. García-Basteiro AL, DiNardo A, Saavedra B, Silva DR, Palmero D, Gegia M, Migliori GB, Duarte R, Mambuque E, Centis R, Cuevas LE, Izco S, Theron G, Point of care diagnostics for tuberculosis. Pulmonology 2018; 24 (2): 73-85
19. GBD 2015 Eastern Mediterranean Region HIV/AIDS Collaborators. Trends in HIV/AIDS morbidity and mortality in Eastern Mediterranean countries, 1990-2015: findings from the Global Burden of Disease 2015 study, International Journal of Public Health 2018; 63(1): 123–136.
20. GBD 2015 Eastern Mediterranean Region LRI Collaborators. Burden of lower respiratory infections in the Eastern Mediterranean Region between 1990 and 2015: findings from the Global Burden of Disease 2015 study. International Journal of Public Health 2018; 63 (1):97-108.
2017
1. Garcia-Basteiro AL, Wong E, Van Oort PM, Cilloniz C, Migliori GB, Singanayagam A. Respiratory infection: insights from Assembly 10 of the European Respiratory Society 2017 Annual Congress. J Thorac Dis 2017; 9 (16): S1559-S1562.
2. GBD Tuberculosis Collaborators. The global burden of tuberculosis: results from the Global Burden of Disease Study 2015. Lancet Infect Dis. 2017; 18(3):261-284.
3. GBD 2016 Risk Factors Collaborators. Global, regional, and national comparative risk assessment of 84 behavioural, environmental and occupational, and metabolic risks or clusters of risks, 1990-2016: a systematic analysis for the Global Burden of Disease Study 2016. Lancet 2017; 390 (10100):1345-1422.
4. GBD 2016 DALYs and HALE Collaborators. Global, regional, and national disabilityadjusted life-years (DALYs) for 333 diseases and injuries and healthy life expectancy (HALE) for 195 countries and territories, 1990-2016: a systematic analysis for the Global Burden of Disease Study 2016. Lancet 2017; 390 (10100):1260-1344.
5. GBD 2016 Disease and Injury Incidence and Prevalence Collaborators. Global, regional, and national incidence, prevalence, and years lived with disability for 328 diseases and injuries for 195 countries, 1990-2016: a systematic analysis for the Global Burden of Disease Study 2016. Lancet 2017; 390 (10100):1211-1259.
6. GBD 2016 Causes of Death Collaborators. Global, regional, and national age-sex specific mortality for 264 causes of death, 1980-2016: a systematic analysis for the Global Burden of Disease Study 2016. Lancet 2017; 390 (10100):1151-1210.
7. GBD 2016 Mortality Collaborators. Global, regional, and national under-5 mortality, adult mortality, age-specific mortality, and life expectancy, 1970-2016: a systematic analysis for the Global Burden of Disease Study 2016. Lancet 2017; 390 (10100):10841150.
8. Mindu E, López-Varela E, Alonso Menendez Y, Mausse Y, Augusto OJ, Gondo K, Muñoz J, Sacarlal J, García-Basteiro AL, Alonso PL, Munguambe K. Caretakers' perspectives of paediatric TB and implications for care-seeking behaviours in Southern Mozambique. Plos One 2017; 14;12(9): e0182213
9. Vergara Gomez A, González-Martín J, García-Basteiro AL. Xpert® MTB/RIF: Usefulness for the diagnosis of tuberculosis and resistance to rifampicin. Medicina Clinica 2017; 149 (9):399-405.
10. Garcia-Basteiro AL, Saavedra B, Cobelens F. The Good, the Bad and the Uglyof the NextGeneration Xpert MTB/RIF® , Arch Bronconeumol 2017; 53 (12) 659-704
11. GBD 2015 Healthcare Access and Quality Collaborators. Healthcare Access and Quality Index based on mortality from causes amenable to personal health care in 195 countries and territories, 1990-2015: a novel analysis from the Global Burden of Disease Study 2015. Lancet 2017; 390 (10091) :231-266.
12. García-Basteiro AL, Mambuque E, den HertogA, Saavedra B, Cuamba I, Oliveras L, Blanco S, Bulo H, Brew J, Cuevas LE, Cobelens F, Nhabomba A, Anthony R. IP-10 Kinetics in the First Week of Therapy are Strongly Associated with Bacteriological Confirmation of Tuberculosis Diagnosis in HIV-Infected Patients. Sci Rep 2017; 7 (1):14302.
13. García-Basteiro AL, Quintó L, Macete E, Bardají A, González R, Nhacolo A, Sigauque B, Sacoor C, Rupérez M, Sicuri E, Bassat Q, Sevene E, Menéndez C. Infant mortality and morbidity associated with preterm and small-for-gestational-age births in Southern Mozambique: A retrospective cohort study. Plos One 2017; 12(2): e0172533.
14. López-Varela E, García-Basteiro AL, JoaquimAugusto O, Fraile O, Bulo H, Ira T, Gondo K, Von Ingen K, Naniche D, Sacarlal J, Alonso P. High Rates of Non-Tuberculous Mycobacteria isolation in Mozambican Children with Presumptive Tuberculosis. Plos One 2017; 12 (4): e0175613.
15. Heyckendorf J, Labugger I, van der Merwe L, Garcia-Basteiro AL, Diacon AH, Lange C, Serial measurements of transrenal mycobacterial DNA as indicators of the early bactericidal activity (EBA) of antituberculosis drugs. Tuberculosis 2017; 01, 102, 31-33
16. Noe A, Riberiro MR, Rui A, Maixenchs M, Sitole L, Munguambe K, Blanco S, Le Souef P, García-Basteiro AL. Knowledge, attitudes and practices regarding tuberculosis care among health workers in Southern Mozambique 2016. BMC Pulmonary Medicine 2017; 17 (1):2
17. Lopez-Varela E, Sequera VG, García-Basteiro AL, Augusto OJ, Munguambe K, Sacarlal J, Alonso PL. Adherence to Childhood Tuberculosis Treatment in Mozambique. Journal of Tropical Pediatrics 2017; 63(2):87-97.
18. Valencia S, León M, Losada I, Sequera V, FernándezQuevedo M, García-Basteiro AL. How do we measure adherence to anti-tuberculosis treatment? Expert Review of Antiinfective Therapy 2017; 15 (2) 157-165
19. García-Basteiro AL, Ribeiro RM, BrewJ, Sacoor C, Valencia S, Bulo H, Cobelens F, Macete E. Tuberculosis on the rise in southern Mozambique (1997-2012). European Respiratory Journal 2017; 49 (3): 393-394.
20. Valencia S, Respeito D, Blanco S, Ribeiro RM, López-Varela E, Sequera VG, Saavedra B, Mambuque E, Morillo MG, Bulo H, Cobelens F, Macete E, Alonso PL, Caminero JA, GarcíaBasteiro AL, Tuberculosis drug resistance in Southern Mozambique: results of a population-level survey in the district of Manhiça. International Journal of Tuberculosis and Lung Disease 2017; 21(4) 446-451.
2016
1. GBD 2015 Risk Factors Collaborators. Global, regional, and national comparative risk assessment of 79 behavioural, environmental and occupational, and metabolic risks or clusters of risks, 1990-2015: a systematic analysis for the Global Burden of Disease Study 2015. Lancet 2016; 388 (10053): 1659-1724.
2. GBD 2015 DALYs and HALE Collaborators. Global, regional, and national disabilityadjusted life-years (DALYs) for 315 diseases and injuries and healthy life expectancy (HALE), 1990-2015: a systematic analysis for the Global Burden of Disease Study 2015. Lancet 2016; 388 (10053): 1603-1658.
3. GBD 2015 SDG Collaborators. Measuring the health-related Sustainable Development Goals in 188 countries: a baseline analysis from the Global Burden of Disease Study 2015. Lancet 2016; 388 (10053) P1813-1850.
4. Ssengooba W, Respeito D, Mambuque E, Blanco S, Bulo H, Mandomando I, de Jong BC, Cobelens FG, García-Basteiro AL. Do Xpert MTB/RIF Cycle Threshold Values Provide Information about Patient Delays for Tuberculosis Diagnosis? Plos One 2016; 11 (9): e0162833.
5. DiaconAH, Lize vander Merwe L, Barnard M, vonGroote-Bidlingmaier F, Lange C, GarcíaBasteiro AL, Sevene E, Ballell L, Barros-Aguirre D, ß-Lactams against TB: A New Trick for an Old Dog? N Engl J Med 2016; (375) :393-394.
6. García-Basteiro AL, Respeito D, Augusto OJ, López-Varela E, Sacoor C, Sequera VG, Casellas A, Bassat Q, Manhiça I, Macete E, Cobelens F, Alonso PL, Poor tuberculosis treatment outcomes in Southern Mozambique (2011-2012). BMC Infect Dis 2016; 16 (1):214
7. García-Basteiro AL, Ruhwald M, Lange C, Design of tuberculosis vaccine trials under financial constraints. Expert Rev Vaccines 2016; 15 (7):799-801.
8. Host-Directed Therapies Network consortium, Host-directed therapies for infectious diseases: current status, recent progress, and future prospects. Lancet Infect Diseases 2016; 16 (4) 2317-2321 e47-63.
9. García-Basteiro AL, Mamudo I, Carrilho C, Ussene E, Castillo P, Chitsungo D, Rodríguez C, Lovane L, Vergara A, Lorenzoni C, Ordi J, MenéndezC, Bassat Q, Martínez MJ. The role of Xpert MTB/RIF in diagnosing pulmonary tuberculosis in post-mortem tissues. Sci Rep 2016; 10; 6: 20703.
10. López-Varela, E, Augusto OJ, Guerra L, Respeito D, Sacoor C, Sacarlal J, Migliori GB, Sotgiu G, Alonso PL, García-Basteiro, AL. Low paediatric Case Detection Rate in Southern Mozambique. Eur Respir Journal 2016; 47(3):1003-5
2015
1. Garcia-Basteiro AL, Mamudo I, Carrilho C, Ussene E, Castillo P, Chitsungo D, Lovane L, Lorenzoni C, Martínez M, Ordi J, Menéndez C, Bassat Q. “Pomegranate” spleen in disseminated tuberculosis. Am J Respir Crit Care Med 2015; 192(3):387-8.
2. Host-Directed Therapies Network HDT-NET Consortium. Garcia-Basteiro A, HostDirected Therapies forTackling Multi-Drug Resistant Tuberculosis: Learning from the Pasteur-Bechamp Debates Clin Infect Diseases 2015; 61 (9)1432–1438.
3. Mena G, García-Basteiro AL, Bayas JM. Hepatitis B and A vaccination in HIV-infected adults: A review. Hum Vaccin Immunother 2015; 11 (11):2582-98.
4. Zumla A, Maeurer M, Chakaya J, Hoelscher M, Ntoumi F, Rustomjee R, Vilaplana C, Yeboah-Manu D, Rasolof V, Munderi P, SinghN, Aklillu E, Padayatchi N, Macete E, Kapata N, Mulenga M, Kibiki G, Mfinanga S, Nyirenda T, Maboko L, Garcia-Basteiro A, Rakotosamimanana N, Bates M, Mwaba P, Reither K, Gagneux S, Edwards S, Mfinanga E, Abdulla S, Cardona PJ, Russell JB, Gant V, Noursadeghi M, Elkington P, Bonnet M, Menendez C, Dieye TN, Diarra B, Maiga A, Aseffa A, Parida S, Wejse C, Petersen E, Kaleebu P, Oliver M, Craig G, Corrah T, Tientcheu L, Antonio M, Rao M, McHugh TD, SheikhA, Ippolito G, Ramjee G, KaufmannSH, Churchyard G, SteynA, Grobusch M, Sanne I, MartinsonN, Madansein R, WilkinsonRJ, Mayosi B, Schito M, Wallis RS, Towards hostdirected therapies for tuberculosis. Nat Rev Drug Discov 2015; (8):511-2.
5. Sequera VG, Valencia S, García-Basteiro AL, Marco A, Bayas JM. Vaccinations in prisons: A shot in the arm for community health. Hum Vaccin Immunotherapy 2015; 11(11):261526.
6. López-Varela E, Augusto OJ, Gondo K, García-Basteiro AL, Fraile O, Ira T, Ribó JL, Bulo H, MuñozJ, Faife LA, Aponte J, Macete E, SacarlalJ, Alonso PL. Incidence ofTuberculosis among young children in rural Mozambique. Pediatr Infect Dis J 2015; 34(7):686-92.
7. García-Basteiro AL, López-Varela E, Augusto OJ, Gondo K, Muñoz J, Sacarlal J, Marais B, Alonso PL, Ribó J. Radiological findings in young children investigated for tuberculosis in Mozambique. PLoS One 2015; 28; 10(5): e0127323.
8. López-Varela E, García-Basteiro AL, Santiago B, Wagner D, van Ingen J, Kampmann B, Non-tuberculous mycobacteria in children: muddying the waters of tuberculosis diagnosis. Lancet Respir Med 2015; 3(3):244-256.
9. García-Basteiro AL, Cobelens F. Triage tests: A new priority A new priority in TB diagnostics. Lancet Respir Med 2015; 3(3):177-8
10. García-Basteiro AL, López-Varela E, Respeito D, González R, Naniche D, ManhiçaI, Macete E, Cobelens F, Alonso PL. High tuberculosis burden among people living with HIV in southern Mozambique. Eur Resp J 2015; 45(2):547-9
1. López-Varela E, García-Basteiro AL. World Health Organization guidelines for childhood tuberculosis management: successes achieved and challenges ahead. Pediatr Infect Dis J 2014; 33(12):1310-1
2. Vilajeliu A, García-Basteiro AL, Goncé A, Bayas JM, Vacunación integral en la embarazada [Comprehensivevaccination in pregnant women]. Progress ofObstetrics and Gynecology 2014; 57(2): 88-96.
3. García-Basteiro AL, López-Varela E, Manhiça I, Macete E, Alonso PL. Mozambique faces challenges in the fight against tuberculosis. Lancet 2014; 383(9913):215-216